Role of clinical pulmonary infection score and serum C-reactive protein in detecting the efficacy of therapeutic choices in the management of Enterobacter aerogenes nosocomial pneumonia
Research and Opinion in Anesthesia and Intensive Care · 2016
DOI: 10.4103/2356-9115.184075 ↗Kurz gefasst
Fachartikel in der Zeitschrift Research and Opinion in Anesthesia and Intensive Care, 2016. Verfasst von JosefZekry Attia und 2 weiteren Autor:innen. Die Arbeit nennt 17 Literaturangaben.
Abstract (Originalsprache)
Introduction and background Nosocomial pneumonia is the second most common nosocomial infection. It is usually bacterial in origin. Nosocomial pneumonia is responsible for 25% of infections in the ICU. Early-onset nosocomial pneumonia tends to carry a better prognosis than does late-onset nosocomial pneumonia.Patients and methods This study was planned to evaluate the role of the clinical pulmonary infection score (CPIS) and C-reactive protein (CRP) in detecting the efficacy of antibiotic therapy chosen for treatment of nosocomial Enterobacter pneumonia. In all, 200 patients admitted to the ICU who had evidence of pneumonia were included in the study. Patients were followed up by evaluating their serum CRP levels and CPIS during the first 8 days of admission.
Results
Enterobacter aerogenes represented 24% of nosocomial pneumonia cases in the study. An overall 70.8% of patients with E. aerogenes detected in culture and sensitivity were sensitive to both amikacin and levofloxacin. Those patients received only amikacin. Sixteen patients provided good response to amikacin. The remaining 18 patients showed poor response to amikacin therapy (proved by insignificant differences between CPIS and CRP on the first and fourth day of admission). In the case of these patients levofloxacin was added to antibiotic therapy and they were followed up for a further 4 days. The results demonstrated that 16 patients provided good response to amikacin and levofloxacin on the fifth and eighth days.
Conclusion
This study demonstrated that CPIS and serum CRP can be used as indicators of the efficacy of antibiotics in nosocomial pneumonia.
Zitieren
APA
Attia, J., Mickhael, H., & Kamel, M. (2016). Role of clinical pulmonary infection score and serum C-reactive protein in detecting the efficacy of therapeutic choices in the management of Enterobacter aerogenes nosocomial pneumonia. Research and Opinion in Anesthesia and Intensive Care. https://doi.org/10.4103/2356-9115.184075
Vancouver
Attia J, Mickhael H, Kamel M. Role of clinical pulmonary infection score and serum C-reactive protein in detecting the efficacy of therapeutic choices in the management of Enterobacter aerogenes nosocomial pneumonia. Research and Opinion in Anesthesia and Intensive Care. 2016. doi:10.4103/2356-9115.184075
BibTeX
@article{Attia2016,
author = {Attia, JosefZekry and Mickhael, HanyKmale and Kamel, MahaYehia},
title = {Role of clinical pulmonary infection score and serum C-reactive protein in detecting the efficacy of therapeutic choices in the management of Enterobacter aerogenes nosocomial pneumonia},
journal = {Research and Opinion in Anesthesia and Intensive Care},
year = {2016},
doi = {10.4103/2356-9115.184075}
}
EUVIMED